Abstract
The origin of cancers is associated with etiology as well as therapeutics. Several studies reveal that malignancies in children can originate in utero. However, a diagnostic approach to distinguish between cancers initiated pre- or postnatally is absent. Here we identified a transcriptional factor FEV (fifth Ewing variant) that was expressed in fetal hematopoietic cells and became silent after birth. We characterized that FEV was essential for the self-renewal of hematopoietic stem cells (HSCs). We next found that FEV was expressed in most infant leukemia samples, but seldom in adult samples, in accord with the known prenatal origins of the former. We further determined the majority of pediatric acute lymphoid leukemia (ALL) and acute myeloid leukemia (AML) were FEV positive. Moreover, FEV knockdown markedly impaired the leukemia-propagating ability of leukemic stem cells. We therefore identified FEV is unique to fetal HSCs and stably expressed in leukemic cells of prenatal origin. It may also provide a tractable therapeutic target.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cohnheim J . Congenitales, quergestreiftes Muskelsarkom der Nieren. Virchows Arch 1875; 65: 64–69.
Durante F . Nesso fisio-patologico tra la struttura dei nei materni e la genesi di alcuni tumori maligni. Arch Memo Observ Chir Prat 1874; 11: 217–226.
Virchow R . Die multiloculäre, ulcerirende Echinokokkengeschwulst der Leber. Verhandlungen der Physicalisch-Medicinischen Gesellschaft 1855; 6: 84–95.
Ford AM, Ridge SA, Cabrera ME, Mahmoud H, Steel CM, Chan LC et al. In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature 1993; 363: 358–360.
Wiemels JL, Cazzaniga G, Daniotti M, Eden OB, Addison GM, Masera G et al. Prenatal origin of acute lymphoblastic leukaemia in children. Lancet 1999; 354: 1499–1503.
Yagi T, Hibi S, Tabata Y, Kuriyama K, Teramura T, Hashida T et al. Detection of clonotypic IGH and TCR rearrangements in the neonatal blood spots of infants and children with B-cell precursor acute lymphoblastic leukemia. Blood 2000; 96: 264–268.
Wiemels JL, Xiao Z, Buffler PA, Maia AT, Ma X, Dicks BM et al. In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia. Blood 2002; 99: 3801–3805.
De Preter K, Vandesompele J, Heimann P, Yigit N, Beckman S, Schramm A et al. Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes. Genome Biol 2006; 7: R84.
Gailani MR, Bale SJ, Leffell DJ, DiGiovanna JJ, Peck GL, Poliak S et al. Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9. Cell 1992; 69: 111–117.
Chen D, Livne-bar I, Vanderluit JL, Slack RS, Agochiya M, Bremner R . Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell 2004; 5: 539–551.
Hong D, Gupta R, Ancliff P, Atzberger A, Brown J, Soneji S et al. Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia. Science 2008; 319: 336–339.
Marshall GM, Carter DR, Cheung BB, Liu T, Mateos MK, Meyerowitz JG et al. The prenatal origins of cancer. Nat Rev Cancer 2014; 14: 277–289.
Greaves MF, Wiemels J . Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer 2003; 3: 639–649.
Peter M, Couturier J, Pacquement H, Michon J, Thomas G, Magdelenat H et al. A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 1997; 14: 1159–1164.
Liu F, Patient R . Genome-wide analysis of the zebrafish ETS family identifies three genes required for hemangioblast differentiation or angiogenesis. Circ Res 2008; 103: 1147–1154.
Wang L, Liu T, Xu L, Gao Y, Wei Y, Duan C et al. Fev regulates hematopoietic stem cell development via ERK signaling. Blood 2013; 122: 367–375.
Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N et al. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. Leukemia 2003; 17: 2318–2357.
Weisser M, Haferlach T, Schoch C, Hiddemann W, Schnittger S . The use of housekeeping genes for real-time PCR-based quantification of fusion gene transcripts in acute myeloid leukemia. Leukemia 2004; 18: 1551–1553.
Fan D, Zhou X, Li Z, Li ZQ, Duan C, Liu T et al. Stem cell programs are retained in human leukemic lymphoblasts. Oncogene 2015; 34: 2083–2093.
Gupta R, Hong D, Iborra F, Sarno S, Enver T . NOV (CCN3) functions as a regulator of human hematopoietic stem or progenitor cells. Science 2007; 316: 590–593.
Duan CW, Shi J, Chen J, Wang B, Yu YH, Qin X et al. Leukemia propagating cells rebuild an evolving niche in response to therapy. Cancer Cell 2014; 25: 778–793.
Goardon N, Marchi E, Atzberger A, Quek L, Schuh A, Soneji S et al. Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia. Cancer Cell 2011; 19: 138–152.
Notta F, Doulatov S, Laurenti E, Poeppl A, Jurisica I, Dick JE . Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 2011; 333: 218–221.
Eppert K, Takenaka K, Lechman ER, Waldron L, Nilsson B, van Galen P et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med 2011; 17: 1086–1093.
Pina C, Enver T . Differential contributions of haematopoietic stem cells to foetal and adult haematopoiesis: insights from functional analysis of transcriptional regulators. Oncogene 2007; 26: 6750–6765.
Zon LI . Intrinsic and extrinsic control of haematopoietic stem-cell self-renewal. Nature 2008; 453: 306–313.
Greaves MF, Maia AT, Wiemels JL, Ford AM . Leukemia in twins: lessons in natural history. Blood 2003; 102: 2321–2333.
Anderson K, Lutz C, van Delft FW, Bateman CM, Guo Y, Colman SM et al. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature 2011; 469: 356–361.
Kong Y, Yoshida S, Saito Y, Doi T, Nagatoshi Y, Fukata M et al. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL. Leukemia 2008; 22: 1207–1213.
le Viseur C, Hotfilder M, Bomken S, Wilson K, Rottgers S, Schrauder A et al. In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties. Cancer Cell 2008; 14: 47–58.
Ford AM, Bennett CA, Price CM, Bruin MC, Van Wering ER, Greaves M . Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia. Proc Natl Acad Sci USA 1998; 95: 4584–4588.
Hjalgrim LL, Madsen HO, Melbye M, Jorgensen P, Christiansen M, Andersen MT et al. Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia. Br J Cancer 2002; 87: 994–999.
Taub JW, Konrad MA, Ge Y, Naber JM, Scott JS, Matherly LH et al. High frequency of leukemic clones in newborn screening blood samples of children with B-precursor acute lymphoblastic leukemia. Blood 2002; 99: 2992–2996.
Gale KB, Ford AM, Repp R, Borkhardt A, Keller C, Eden OB et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA 1997; 94: 13950–13954.
Ke F CY, Tang JY, Hong DL . Tracking down the origin of stem cell programs in cancer cells. Ann Hematol Oncol 2015; 2: 1054–1055.
Fasching K, Panzer S, Haas OA, Borkhardt A, Marschalek R, Griesinger F et al. Presence of N regions in the clonotypic DJ rearrangements of the immunoglobulin heavy-chain genes indicates an exquisitely short latency in t(4;11)-positive infant acute lymphoblastic leukemia. Blood 2001; 98: 2272–2274.
Maia AT, Koechling J, Corbett R, Metzler M, Wiemels JL, Greaves M . Protracted postnatal natural histories in childhood leukemia. Genes Chromosomes Cancer 2004; 39: 335–340.
Acknowledgements
We thank M Greaves for critical comments on the paper. We thank B Zhang for the provision of fev:GFP zebrafish. B Zhao and C Duan are also acknowledged for their technical assistance in flow-sorting and mouse injection, respectively. This work was supported by grants from the National Basic Research Program of China (Grant No. 2012CB967001 to D-LH and 2010CB945300 and 2011CB943900 to FL) and the National Natural Science Foundation of China (Grant Nos. 81120108006, 90919055 and 91442106 to D-LH and 31425016 to FL).
Author contributions
T-HL designed and performed the experiments and analyzed the results; Y-JT and T-HL collected and analyzed the clinical data; LW and FL performed zebrafish experiments; YH and Q-JY collected human fetal liver and BM cells; X-LG, YZ, LC, HZ, XL and L-HZ collected human CB cells; J-YT, B-SL, J-QM and L-GL collected patient samples and related clinical information; AF detected FEV expression and analyzed data; TE, FL and G-QC discussed the data and contributed to the writing of the manuscript; D-LH supervised the project, designed the experiments and wrote the paper.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Rights and permissions
About this article
Cite this article
Liu, TH., Tang, YJ., Huang, Y. et al. Expression of the fetal hematopoiesis regulator FEV indicates leukemias of prenatal origin. Leukemia 31, 1079–1086 (2017). https://doi.org/10.1038/leu.2016.313
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2016.313